You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美中嘉和(02453.HK):國家衞健委已批准公司的質子治療設備許可證申請
格隆匯 09-15 18:19

格隆匯9月15日丨美中嘉和(02453.HK)公吿,廣州泰和腫瘤醫院有限公司(一家於2011年6月29日在中華人民共和國註冊成立的有限責任公司,由公司擁有80%的權益,以廣州泰和腫瘤醫院的商號經營)已採購了一套定製的質子治療設備,並開始了該質子治療設備的臨牀試驗。

公司已於2024年4月29日就質子治療設備向中華人民共和國國家衞生健康委員會提交了大型醫用設備配置許可證("許可證")申請。董事會欣然宣佈,國家衞健委已於2024年9月13日批准公司的許可證申請。

質子治療服務的營運將於完成若干部署後儘快開始。公司將適時提供有關其計劃中的質子治療服務重大進展的更多最新資料。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account